Truth Behind Non-FDA Approved Topical Finasteride

Highlights:

A new study promoting non-FDA approved topical Finasteride has been criticized by the German RX Journal for concerns over accuracy and ethics
Some experts caution that the potential side effects of Finasteride, including sexual dysfunction and depression, may not be fully understood
The controversy highlights the importance of thoroughly researching and evaluating any medication before use

The use of non-FDA-approved topical Finasteride has been a hot topic in the hair loss community, with many individuals seeking out this treatment as an alternative to oral Finasteride. However, a recent study has been called into question by a top German RX journal, citing concerns over the accuracy and ethics of the study.

Depressive Symptoms and Suicidal Thoughts in Former Finasteride Users Observed by Researcher
Men who used hair loss drug finasteride and later developed persistent sexual side effects also have a high risk of developing depression and suicidal thoughts.

‘The controversy over topical Finasteride proves the importance of doing your research and considering potential risks before taking any new drug.’

Tweet it Now

Examining the Validity and Ethical Concerns of the Study Promoting Non-FDA Approved Topical Finasteride

The study in question is one that was used to promote the use of a non-FDA-approved topical Finasteride product. The study claimed that the product was effective at stopping hair loss and promoting hair growth, and was therefore a viable alternative to oral Finasteride. However, the study has been criticized for several reasons.

Firstly, the study has been accused of being biased, as it was funded by the manufacturer of the topical Finasteride product. This raises concerns about the accuracy and reliability of the study's results. Additionally, the study has been criticized for its small sample size and lack of controls, which further call into question the validity of the results.

Finasteride Saves Men from Prostate Cancer, Doesn't Increase Risk of Death: Study
A drug shown to reduce risk of prostate cancer by more than a third has no impact on lifespan but further reduces the risk of prostate cancer.

Potential Risks and Side Effects of Non-FDA Approved Topical Finasteride

Moreover, the use of non-FDA-approved topical Finasteride has been a contentious issue in the hair loss community due to potential side effects such as scalp irritation, itching, and dryness. Oral Finasteride, on the other hand, has been extensively tested and approved by the FDA for the treatment of hair loss in men. It is also important to note that oral Finasteride has been proven to be effective in the treatment of hair loss, with numerous studies demonstrating its efficacy.

The PFS Foundation, a non-profit organization dedicated to raising awareness of the potential dangers of Finasteride use, has also spoken out against the use of non-FDA-approved topical Finasteride. The Foundation has highlighted the need for rigorous testing and regulation of hair loss treatments to ensure the safety and efficacy of these products.

Finasteride is Safe and Effective Preventive Strategy for Prostate Cancer
Finasteride, a generic hormone-blocking drug, could reduce the risk of prostate cancer and appears to be safe and inexpensive preventive strategy.

Importance of Thorough Research and Evaluation Before Taking New Medications

In conclusion, the use of non-FDA-approved topical Finasteride is a controversial topic that requires careful consideration and scrutiny. The recent study promoting the use of such products has been called into question by a top German RX journal, and concerns have been raised about its accuracy and ethics. While there may be alternative treatments for hair loss, it is important to prioritize safety and efficacy and to rely on products that have been extensively tested and approved by regulatory bodies such as the FDA.

Source-Medindia

Finasteride Does Not Increase Risk of Prostate Cancer Death
Finasteride, a common hormone-blocking drug, reduces men's risk of getting prostate cancer without increasing their risk of dying from the disease, revealed research.